Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Mineralys Therapeutics, Inc.. A complete text table follows the diagram.
Clinical development targets hypertension through a focused therapeutic platform.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Total reported revenue | 1 | $45.3M | Reported filing total |
| Cardiovascular development platform | 2 | $45.3M | Company-specific editorial view |
| From | To | Value |
|---|---|---|
| Total reported revenue | Cardiovascular development platform | $45.3M |